CE
NASDAQ · CERE
Cerevel Therapeutics Holdings, Inc.
Healthcare · Biotechnology
$44.96
Up+$0.33 (+0.74%)
Updated Sep 11, 2026, 1:43 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 8.19B
- P/E ratio
- -16.83
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 15.03M
- Avg. volume
- 2.11M
Price performance
CERE price history
1M range · 0 trading sessions · Daily adjusted prices
CERE does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest CERE news
The latest Smart Investors Daily articles mentioning CERE.
Stock researchCompany · Financials
Loading stock research…
